These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3729478)

  • 21. [Neoadjuvant treatment with cisplatin, 5-FU and folinic acid in advanced head and neck cancer].
    Contreras J; Medina JA; Albero A; Herruzo I; Marina E; Azcoaga JM; Bretón JJ
    Acta Otorrinolaringol Esp; 1994; 45(2):87-91. PubMed ID: 8086215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A critical consideration of the combined radiochemotherapy of head and neck tumors].
    Schlappack O; Springer B; Hainz A
    Strahlenther Onkol; 1994 Jan; 170(1):25-9. PubMed ID: 8303574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
    Haraf DJ; Stenson K; List M; Witt ME; Weichselbaum RR; Vokes EE
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-68-S2-71. PubMed ID: 9045341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of paclitaxel in the treatment of head and neck cancer.
    Vokes EE; Haraf DJ; Stenson K; Stupp R; Malone D; Levin J; Weichselbaum RR
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):8-12. PubMed ID: 7481866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
    Brizel DM; Murphy BA; Rosenthal DI; Pandya KJ; Glück S; Brizel HE; Meredith RF; Berger D; Chen MG; Mendenhall W
    J Clin Oncol; 2008 May; 26(15):2489-96. PubMed ID: 18487568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy.
    Schlemmer HP; Becker M; Bachert P; Dietz A; Rudat V; Vanselow B; Wollensack P; Zuna I; Knopp MV; Weidauer H; Wannenmacher M; van Kaick G
    Cancer Res; 1999 May; 59(10):2363-9. PubMed ID: 10344745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
    BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
    Mantovani G; Proto E; Massa E; Mulas C; Madeddu C; Mura L; Mudu MC; Astara G; Murgia V; Gramignano G; Ferreli L; Camboni P; Lusso MR; Mocci M; Tore G; Mura M; Amichetti M; Maccio A
    Int J Oncol; 2002 Feb; 20(2):419-27. PubMed ID: 11788911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemoprevention and FAR therapy regimen comprised of 5-fluorouracil, vitamin A and radiation].
    Yamamoto T
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):454-60. PubMed ID: 11329778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
    Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
    Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of head and neck neoplasms].
    Imano Y; Suzuki H; Hayashizaki K; Kaneko T
    Gan No Rinsho; 1989 Jan; Spec No():108-18. PubMed ID: 2915469
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adjuvant chemotherapy with TS-1 for head and neck cancer--side effect of two-week application followed by one-week rest regimen].
    Itoi A; Takashima M; Ishimasa H; Murata H; Tomoda K
    Gan To Kagaku Ryoho; 2006 May; 33(5):617-20. PubMed ID: 16685159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel (Taxol) for the treatment of head and neck cancer.
    Forastiere AA
    Semin Oncol; 1994 Oct; 21(5 Suppl 8):49-52. PubMed ID: 7939763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.
    Maguire PD; Meyerson MB; Neal CR; Hamann MS; Bost AL; Anagnost JW; Ungaro PC; Pollock HD; McMurray JE; Wilson EP; Kotwall CA
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):698-704. PubMed ID: 14967423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
    Altmann S; Hoffmanns H
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.